Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of East Anglia Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Kent Featured PhD Programmes
University College London Featured PhD Programmes
10 miles

Cardiovascular Science PhD Projects, Programs & Scholarships

We have 13 Cardiovascular Science PhD Projects, Programs & Scholarships

  • Cardiovascular Science ×
  • clear all
Order by 
Showing 1 to 10 of 13
  Mesenchymal Stem Cell-derived Exosomes as Immunomodulatory Therapeutic Agents in the Infarcted Heart: Role of Dendritic Cells
  Prof C Emanueli, Dr S Sattler
Application Deadline: 31 January 2019
Applications are invited for a BHF 4 year MRes/PhD studentship starting in October 2019 at the Imperial Centre for Translational and Experimental Medicine (ICTEM), Hammersmith Campus.
  Regulation of myocardial contractility mediated by extracellular vesicles and studied using ultrathin myocardial slices
  Prof C Terracciano, Prof C Emanueli
Application Deadline: 31 January 2019
Applications are invited for a BHF 4 year MRes/PhD studentship starting in October 2019 at the Imperial Centre for Translational and Experimental Medicine (ICTEM), Hammersmith Campus.
  Regulation of SOX17 by HOXa5: a therapeutic target in pulmonary arterial hypertension
  Dr C Rhodes, Prof M Wilkins, Prof J Ferrer, Dr I Cebola
Application Deadline: 31 January 2019
Applications are invited for a BHF 4 year MRes/PhD studentship starting in October 2019 at the Imperial Centre for Translational and Experimental Medicine (ICTEM), Hammersmith Campus.
  The role of the immune system in mitochondria-mediated cardiomyopathies
  Dr S Sattler, Dr T Rodriguez
Application Deadline: 31 January 2019
Applications are invited for a BHF 4 year MRes/PhD studentship starting in October 2019 at the Imperial Centre for Translational and Experimental Medicine (ICTEM), Hammersmith Campus.
  Extracellular vesicles as indicators of immune status and outcome in sepsis patients
  Dr K P O'Dea, Prof AC Gordon, Dr M Takata
Application Deadline: 7 January 2019
Sepsis is a major health care burden with unacceptably high rates of mortality. The underlying pathogenic mechanisms are multifactorial involving dysfunctional immune and metabolic responses to infection.
  MRC DiMeN Doctoral Training Partnership: Developing novel therapies for babies born with univentricular hearts
  Prof H Arthur, Dr A Lawrie
Application Deadline: 21 January 2019
Outstanding graduate scientists are invited to apply for a PhD Studentship to study the molecular mechanisms that cause detrimental pulmonary vascular remodelling in babies born with univentricular hearts, and to develop treatments that will prevent this problem and protect the infant lungs through childhood.
  MRC DiMeN Doctoral Training Partnership: Discovering the neuronal signalling mechanism at the heart of cardiac arrhythmias
  Dr I Jayasinghe, Dr N Gamper, Prof E White
Application Deadline: 21 January 2019
Background. Cardiac arrhythmias are a leading cause of mortality and long-term morbidity worldwide. Over 25% of these originate in the heart’s electrically-autonomous (pacemaking) cells without a detectable heart attack.
  MRC DiMeN Doctoral Training Partnership: Mining large international genetic datasets to identify new therapeutic targets in giant cell arteritis through innovative genetic methodology
  Prof A Morgan, Prof JH Barrett, Dr A Mälarstig
Application Deadline: 21 January 2019
Giant cell arteritis (GCA) is the commonest primary systemic vasculitis, occurring exclusively after 50yrs. Irreversible ischaemic complications, including blindness, occur in 19% of UK patients, despite prompt treatment.
  MRC DiMeN Doctoral Training Partnership: The direct effect of statins on cardiovascular function
  Dr M Cross, Prof J Schneider, Prof H Poptani, Dr B Wilm
Application Deadline: 21 January 2019
Cardiovascular disease (CVD) is the leading cause of death in the western world. The incidence and prevalence of CVD is highest among the elderly due to the deleterious effects of advancing age on the heart and blood vessels1.
  MRC DiMeN Doctoral Training Partnership: Developing non-invasive imaging strategies to investigate the effect of kidney disease on cardiovascular health and assess the ameliorative effect of a regenerative medicine therapy
  Prof P Murray, Prof J Schneider, Prof H Poptani, Dr B Wilm
Application Deadline: 21 January 2019
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). The strong association between CKD and CVD has been recognised for many years, but the mechanisms by which CKD causes CVD are largely unknown.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.